These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 5010075)

  • 61. Serotonin accumulation after monoamine oxidase inhibition. Effects of decreased impulse flow and of some anti-depressants and hallucinogens.
    Meek JL; Fuxe K
    Biochem Pharmacol; 1971 Mar; 20(3):693-706. PubMed ID: 5150164
    [No Abstract]   [Full Text] [Related]  

  • 62. [Effect of new potential psychotropic drug, 8-(trifluoromethyl)-1,2,3,4,5-benzopentathiepin-6-amine hydrochloride, on the expression of serotonin-related genes in mouse brain].
    Kulikov AV; Tikhonova MA; Kulikova EA; Khomenko TM; Korchagina DV; Volcho KP; Salachutdinov HF; Popova NK
    Mol Biol (Mosk); 2011; 45(2):282-8. PubMed ID: 21634115
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Microspectrofluorimetric studies on central 5-hydroxytryptamine neurons.
    Jonsson G; Einarsson P; Fuxe K; Hallman H
    Adv Biochem Psychopharmacol; 1974; 10():55-65. PubMed ID: 4276959
    [No Abstract]   [Full Text] [Related]  

  • 64. Effect of oxygen on brain serotonin metabolism in rats.
    Diaz PM; Ngai SH; Costa E
    Am J Physiol; 1968 Mar; 214(3):591-4. PubMed ID: 5300205
    [No Abstract]   [Full Text] [Related]  

  • 65. Increased synthesis and utilization of serotonin in the central nervous system of the rat during paradoxical sleep deprivation.
    Hery F; Pujol JF; Lopez M; Macon J; Glowinski J
    Brain Res; 1970 Jul; 21(3):391-403. PubMed ID: 4318998
    [No Abstract]   [Full Text] [Related]  

  • 66. Evidence for the synthesis and storage of 5-hydroxytryptamine in two separate pools in the brain.
    Shields PJ; Eccleston D
    J Neurochem; 1973 Mar; 20(3):881-8. PubMed ID: 4703797
    [No Abstract]   [Full Text] [Related]  

  • 67. Lack of effect of various endocrine manipulations on tryptophan hydroxylase activity of individual nuclei of the hypothalamus, limbic system, and midbrain of the rat.
    Kizer JS; Palkovits M; Kopin IJ; Saavedra JM; Brownstein MJ
    Endocrinology; 1976 Mar; 98(3):743-7. PubMed ID: 1261494
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Effect of dorsal raphe nucleus stimulation on unit discharges of light-sensitive neurons of suprachiasmatic nucleus in rats].
    Yu GD; Wei XP; Zhang HQ; Xu S; Yin QZ; Tang PL; Qian ZM
    Sheng Li Xue Bao; 1997 Jun; 49(3):314-20. PubMed ID: 9812817
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Regulation of mouse brain tryptophan hydroxylase activity.
    Cho TM; Loh HH
    Pharmacology; 1973; 10(4):215-9. PubMed ID: 4762216
    [No Abstract]   [Full Text] [Related]  

  • 70. [Synaptosomal transport of cerebral tryptophan and tyrosine. Stimulation of the rate of uptake after administration of reserpine or monoamine oxidases inhibitor].
    Belin MF; Chouvet G; Pujol JF
    Biochem Pharmacol; 1974 Feb; 23(3):587-97. PubMed ID: 4822744
    [No Abstract]   [Full Text] [Related]  

  • 71. Accumulation and disappearance of 3H-5-hydroxytryptamine formed from 3H-tryptophan in mouse brain; effect of LSD-25.
    Schubert J; Nybäck H; Sedvall G
    Eur J Pharmacol; 1970 May; 10(2):215-24. PubMed ID: 5446376
    [No Abstract]   [Full Text] [Related]  

  • 72. Brain tryptophan hydroxylase: purification of, production of antibodies to, and cellular and ultrastructural localization in serotonergic neurons of rat midbrain.
    Joh TH; Shikimi T; Pickel VM; Reis DJ
    Proc Natl Acad Sci U S A; 1975 Sep; 72(9):3575-9. PubMed ID: 1059145
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The effects of pargyline on overflow of transmitter and uptake of noradrenaline in the cat spleen.
    Blakeley AG; Powis G; Summers RJ
    Br J Pharmacol; 1973 Apr; 47(4):719-28. PubMed ID: 4353241
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Determination of monoamine oxidase concentrations in rat liver by inhibitor binding.
    Gomez N; Unzeta M; Tipton KF; Anderson MC; O'Carroll AM
    Biochem Pharmacol; 1986 Dec; 35(24):4467-72. PubMed ID: 3790166
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Regional 5-HT analysis in Roman high- and low-avoidance rats following MAO inhibition.
    Driscoll P; Dedek J; Martin JR; Baettig K
    Eur J Pharmacol; 1980 Dec; 68(3):373-6. PubMed ID: 6162652
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Aspects of the biogenic amine-depleting activity of ethyl 3-acetamido-4H-pyrrolo-[3,4-c]isoxazole-5(6H)-carboxylate in the rat.
    Lippmann W; Wishnick M
    Br J Pharmacol Chemother; 1968 Jun; 33(2):257-65. PubMed ID: 5664146
    [No Abstract]   [Full Text] [Related]  

  • 77. The effects of drugs on serotonergic nerve terminals.
    Bloom FE; Costa E
    Adv Cytopharmacol; 1971 May; 1():379-95. PubMed ID: 5163249
    [No Abstract]   [Full Text] [Related]  

  • 78. Modification of norepinephrine synthesis in intact tissue dy drugs and during short-term adrenergic nerve stimulation.
    Weiner N; Cloutier G; Bjur R; Pfeffer RI
    Pharmacol Rev; 1972 Jun; 24(2):203-21. PubMed ID: 4405385
    [No Abstract]   [Full Text] [Related]  

  • 79. Serotonin-containing neuronal perikarya and terminals: differential effects of P-chlorophenylalanine.
    Aghajanian GK; Kuhar MJ; Roth RH
    Brain Res; 1973 May; 54():85-101. PubMed ID: 4267802
    [No Abstract]   [Full Text] [Related]  

  • 80. Inhibitory effect of chlorpromazine on the syndrome of hyperactivity produced by L-tryptophan or 5-methoxy-N,N-dimethyltryptamine in rats treated with a monoamine oxidase inhibitor.
    Grahame-Smith DG
    Br J Pharmacol; 1971 Dec; 43(4):856-64. PubMed ID: 4261561
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.